VKH
ADMS

Virtu KCG Holdings’s Adamas Pharmaceuticals ADMS Stock Holding History

Virtu KCG Holdings’s Portfolio ADMS Stock Details ADMS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		$184K Buy
+10,538
New +$174K 0.01% 2194

Other funds holding ADMS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
BWCA
Brenner West Capital Advisors New York $804M AUM 16.19% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
EMFAT
Emerald Mutual Fund Advisers Trust Leola, Pennsylvania $2.06B AUM 106.87% 1-Year Est. Return
EA
Emerald Advisers Leola, Pennsylvania $3.16B AUM 109.58% 1-Year Est. Return
RPAM
Rhenman & Partners Asset Management Stockholm, Sweden $810M AUM 30.2% 1-Year Est. Return

Virtu KCG Holdings's ADMS Position: Q2 2017 in Review

Virtu KCG Holdings opened a new position in Adamas Pharmaceuticals (ADMS) in Q2 2017: 10,538 shares worth $184K. The stake represents 0.01% of the portfolio and ranks #2194 among its holdings.

77 funds tracked by Wall St. Rank hold ADMS as of Q2 2017.

  • Virtu KCG Holdings held 10,538 shares of Adamas Pharmaceuticals worth $184K as of Q2 2017.
  • Adamas Pharmaceuticals was a new Virtu KCG Holdings position in Q2 2017.
  • Adamas Pharmaceuticals made up 0.01% of Virtu KCG Holdings's portfolio in Q2 2017, its #2194 holding.
  • 77 funds tracked by Wall St. Rank held Adamas Pharmaceuticals as of Q2 2017.

Based on Virtu KCG Holdings's 13F filing for Q2 2017, filed 11 Aug 2017.